JAMDA
April 27, 2018
Showing 791 - 800 of 7791 results
JAMDA
November 1, 2021
Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents
JAMDA
June 12, 2021
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening
COVID-19 disproportionately impacts residents in long-term care facilities. Our objective was to quantify the presence and magnitude of antibody response in vaccinated, older adult residents at assisted living, personal care, and independent living communities.
JAMDA
January 15, 2022
Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
Caring for the Ages
March 29, 2016
Anticancer Drug Bexarotene Inhibits Build-Up of Toxic Alzheimer’s Protein
JAMDA
February 6, 2022
Anticholinergic Burden and Increased Excessive Daytime Sleepiness in Older Women
JAMDA
July 22, 2018
Anticholinergic Burden is Associated With Increased Mortality in Older Patients With Dependency Discharged From Hospital
To determine whether anticholinergic burden may predict differently 1-year mortality in older patients discharged from acute care hospitals with or without dependency in basic activities of daily living (BADL).
JAMDA
July 21, 2020
Anticholinergic Burden Measures Predict Older People's Physical Function and Quality of Life: A Systematic Review
This systematic review (PROSPERO CRD42019115918) compared the evidence behind anticholinergic burden (ACB) measures and their ability to predict changes in older people's physical function and quality of life.
JAMDA
July 20, 2020
Anticholinergic Drug Burden and Delirium: A Systematic Review
To investigate the association between anticholinergic drug burden (ADB), measured with anticholinergic drug scales, and delirium and delirium severity.
JAMDA
October 3, 2014